FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145795890> ?p ?o ?g. }

• W2145795890 abstract "The presence of circulating tumor cells (CTC) in breast cancer might be associated with stem cell-like tumor cells which have been suggested to be the active source of metastatic spread in primary tumors. Furthermore, to be able to disseminate and metastasize, CTC must be able to perform epithelial-mesenchymal transition (EMT). We studied the expression of three EMT markers and the stem cell marker ALDH1 in CTC from 502 primary breast cancer patients. Data were correlated with the presence of disseminated tumor cells (DTC) in the bone marrow (BM) and with clinicopathological data of the patients. A total of 2 × 5 ml of blood was analyzed for CTC with the AdnaTest BreastCancer (AdnaGen AG) for the detection of EpCAM, MUC-1, HER2 and beta-Actin transcripts. The recovered c-DNA was additionally multiplex tested for three EMT markers [TWIST1, Akt2, phosphoinositide kinase-3 (PI3Kα)] and separately for the tumor stem cell marker ALDH1. The identification of EMT markers was considered positive if at least one marker was detected in the sample. Two BM aspirates from all patients were analyzed for DTC by immunocytochemistry using the pan-cytokeratin antibody A45-B/B3. Ninety-seven percent of 30 healthy donor samples investigated were negative for EMT and 95% for ALDH1 transcripts, respectively. CTC were detected in 97/502 (19%) patients. At least one of the EMT markers was expressed in 29% and ALDH1 was present in 14% of the samples, respectively. Interestingly, 5% of the ALDH1-positive and 18% of the EMT-positive patients were CTC-negative based on the cut-off level determined for CTC-positivity applying the AdnaTest BreastCancer. DTC in the BM were detected in 107/502 (21%) patients and no correlation was found between BM status and CTC positivity (P = 0.41). The presence of CTC, EMT and ALDH1 expression was not correlated to any of the prognostic clinical markers. Our data indicate that (1) a subset of primary breast cancer patients shows EMT and stem cell characteristics and (2) the currently used detection methods for CTC are not efficient to identify a subtype of CTC which underwent EMT. (3) The clinical relevance on prognosis and therapy response has to be further evaluated in a prospective trial." @default.
• W2145795890 created "2016-06-24" @default.
• W2145795890 creator A5003887595 @default.
• W2145795890 creator A5025408460 @default.
• W2145795890 creator A5032246802 @default.
• W2145795890 creator A5052434013 @default.
• W2145795890 creator A5086791040 @default.
• W2145795890 date "2012-01-20" @default.
• W2145795890 modified "2023-10-17" @default.
• W2145795890 title "Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells" @default.
• W2145795890 cites W1970517999 @default.
• W2145795890 cites W1980299983 @default.
• W2145795890 cites W1985447080 @default.
• W2145795890 cites W1985748412 @default.
• W2145795890 cites W1989343897 @default.
• W2145795890 cites W1990877651 @default.
• W2145795890 cites W1996302215 @default.
• W2145795890 cites W2009094422 @default.
• W2145795890 cites W2014691022 @default.
• W2145795890 cites W2015595536 @default.
• W2145795890 cites W2018579586 @default.
• W2145795890 cites W2018935795 @default.
• W2145795890 cites W2022664855 @default.
• W2145795890 cites W2023316892 @default.
• W2145795890 cites W2028298372 @default.
• W2145795890 cites W2029443168 @default.
• W2145795890 cites W2039957063 @default.
• W2145795890 cites W2040964625 @default.
• W2145795890 cites W2044514360 @default.
• W2145795890 cites W2048200020 @default.
• W2145795890 cites W2049394804 @default.
• W2145795890 cites W2058935670 @default.
• W2145795890 cites W2062187838 @default.
• W2145795890 cites W2063429605 @default.
• W2145795890 cites W2064419741 @default.
• W2145795890 cites W2068503417 @default.
• W2145795890 cites W2085322507 @default.
• W2145795890 cites W2095671568 @default.
• W2145795890 cites W2101500128 @default.
• W2145795890 cites W2102734247 @default.
• W2145795890 cites W2102949315 @default.
• W2145795890 cites W2105504936 @default.
• W2145795890 cites W2105739438 @default.
• W2145795890 cites W2111976640 @default.
• W2145795890 cites W2115971576 @default.
• W2145795890 cites W2116388783 @default.
• W2145795890 cites W2120426806 @default.
• W2145795890 cites W2120656656 @default.
• W2145795890 cites W2121148175 @default.
• W2145795890 cites W2138240181 @default.
• W2145795890 cites W2145056062 @default.
• W2145795890 cites W2152835558 @default.
• W2145795890 cites W2155008430 @default.
• W2145795890 cites W2155390148 @default.
• W2145795890 cites W2156500288 @default.
• W2145795890 cites W2158210303 @default.
• W2145795890 cites W2159640574 @default.
• W2145795890 cites W2271721498 @default.
• W2145795890 cites W2414273656 @default.
• W2145795890 doi "https://doi.org/10.1186/bcr3099" @default.
• W2145795890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3496132" @default.
• W2145795890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22264265" @default.
• W2145795890 hasPublicationYear "2012" @default.
• W2145795890 type Work @default.
• W2145795890 sameAs 2145795890 @default.
• W2145795890 citedByCount "263" @default.
• W2145795890 countsByYear W21457958902012 @default.
• W2145795890 countsByYear W21457958902013 @default.
• W2145795890 countsByYear W21457958902014 @default.
• W2145795890 countsByYear W21457958902015 @default.
• W2145795890 countsByYear W21457958902016 @default.
• W2145795890 countsByYear W21457958902017 @default.
• W2145795890 countsByYear W21457958902018 @default.
• W2145795890 countsByYear W21457958902019 @default.
• W2145795890 countsByYear W21457958902020 @default.
• W2145795890 countsByYear W21457958902021 @default.
• W2145795890 countsByYear W21457958902022 @default.
• W2145795890 countsByYear W21457958902023 @default.
• W2145795890 crossrefType "journal-article" @default.
• W2145795890 hasAuthorship W2145795890A5003887595 @default.
• W2145795890 hasAuthorship W2145795890A5025408460 @default.
• W2145795890 hasAuthorship W2145795890A5032246802 @default.
• W2145795890 hasAuthorship W2145795890A5052434013 @default.
• W2145795890 hasAuthorship W2145795890A5086791040 @default.
• W2145795890 hasBestOaLocation W21457958901 @default.
• W2145795890 hasConcept C111683008 @default.
• W2145795890 hasConcept C118646709 @default.
• W2145795890 hasConcept C121608353 @default.
• W2145795890 hasConcept C126322002 @default.
• W2145795890 hasConcept C136302470 @default.
• W2145795890 hasConcept C142724271 @default.
• W2145795890 hasConcept C143998085 @default.
• W2145795890 hasConcept C204232928 @default.
• W2145795890 hasConcept C2779012181 @default.
• W2145795890 hasConcept C2779013556 @default.
• W2145795890 hasConcept C2780140570 @default.
• W2145795890 hasConcept C28328180 @default.
• W2145795890 hasConcept C502942594 @default.
• W2145795890 hasConcept C530470458 @default.
• W2145795890 hasConcept C54355233 @default.

• next